Sentence examples for temporary therapy from inspiring English sources

It emphasizes the case of novel solutions that are specific to the sector of temporary therapy, especially in surgery with degradable systems, in pharmacology with drug transport and drug targeting based on soft matter, and in tissue engineering.

Complete response was observed in an 83-year-old platinum-naïve patient, who experienced grade 3 skin toxicity that caused temporary therapy withdrawal.

We chose 90 days as the baseline of our study to ensure enough time to switch from a temporary needed therapy to the intended treatment and to exclude patients who only have to undergo renal replacement therapy for a short period of time.

92 In patients taking temporary anticoagulant therapy for venous thromboembolism, endotherapy may need to be delayed until treatment is completed or until antithrombotic therapy has been established for at least 1 month and temporary withdrawal does not appear to pose a significantly increased thromboembolic risk.

General treatment of bleeding disorders consists mainly of temporary replacement therapy by transfusion.

A novel 32P brachytherapy source has been in use at our institution intraoperatively for temporary radiation therapy of the spinal dura and other localized tumors.

The current treatment provides only symptomatic relief by offering temporary palliative therapy which declines the rate of cognitive impairment associated with AD.

This protocol involves a temporary immunosuppressive therapy with cyclosporin A stopped during the first year after bilateral grafting, azathioprin and prednisolone progressively decreased then stopped over the following months.

The primary outcome is time to treatment failure, defined as either HbA1c > 8% for 6 months or inability to wean from temporary insulin therapy within 3 months following an acute metabolic decompensation.

93 In patients with 'low-risk' conditions for thromboembolic events, such as uncomplicated atrial fibrillation or bioprosthetic cardiac valves, the practice of temporary antithrombotic therapy cessation for up to 5 days before endoscopy appears safe.

The primary objective was to compare the three treatment arms (M, M+R, and M+L) on time to treatment failure, i.e., loss of glycemic control defined as either HbA1c ≥8% (64 mmol/mol) over a 6-month period or inability to wean from temporary insulin therapy within 3 months after acute metabolic decompensation.